Blue Paradigm Pharmaceuticals Llp - Company overview

Blue Paradigm Pharmaceuticals Llp is an MCA-registered Indian LLP: a Limited Liability Partnership (LLPIN/FCRN AAX-0199). Business overview …

2021-05-14 Navi Mumbai, Maharashtra Active LLP
View plans
BP Blue Paradigm Pharmaceuticals Llp
Complete Company Report + Documents
  • MCA filings & documents
  • P&L, balance sheet, cash flow & ratios
  • Year-wise charts & analysis
₹700 ₹349 50% off New user
Or enjoy up to 50% off with credits View credit packages
MCA Documents Access
  • Public filings
  • Bulk ZIP download
  • Dashboard access (1 year)
₹300 ₹149 50% off New user
Or enjoy up to 50% off with credits View credit packages

Key Metrics

AUTHORISED CAPITAL
1.00 Lakh
PAID-UP CAPITAL
-
COMPANY AGE
5 Years 0 Months
since 2021-05-14
LAST FILING WITH ROC
2024-03-31
Last AGM: 2025-03-31
OPEN CHARGES
-
-
SATISFIED CHARGES
-
-
REVENUE
PROFIT / LOSS
EBITDA
NET WORTH
TOTAL ASSETS
TOTAL MONEY RAISED
ACTIVE GST
-

About Blue Paradigm Pharmaceuticals Llp

Blue Paradigm Pharmaceuticals Llp is an MCA-registered Indian LLP: a Limited Liability Partnership (LLPIN/FCRN AAX-0199). Business overview includes Pharma (Pharmaceutical Retailers & Distributors), incorporated on May 14, 2021 (5+ years old), headquartered in Navi Mumbai, Maharashtra, India. The LLP is currently Active. It has 2 active partners.

Pharmaceutical Retailers & Distributors
  • Location Office No 1302, Building No A1, Sector 1, Mbp, Mahape, Navi Mumbai, Maharashtra - 400710
CIN / LLPINAAX-0199
Company No.-
ClassificationLimited Liability Partnership
Incorporation Date2021-05-14
Date of AGM2025-03-31
Date of Balance Sheet2024-03-31
Listing Status-
ROC CodeRoc Mumbai
PAN
LEI Number
Active Compliance-

Financial Performance of Blue Paradigm Pharmaceuticals Llp

Revenue Over The Year
2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025
Growth (7 Year) ▲ 38.3% Growth (3 Year) ▼ -9.9%
Profit/Loss Over The Year
2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025
Growth (7 Year) ▼ 65.1% Growth (3 Year) ▼ 60.7%
Values are in Mixed (K, L, Cr)
Metrics FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Revenue 2,20,083.04 cr2,35,431.21 cr2,51,890.00 cr2,18,400.00 cr1,95,200.00 cr1,72,000.00 cr1,59,000.00 cr
Profit/Loss 13,969.70 cr 4,810.00 cr 12,200.00 cr 9,100.00 cr -8,200.00 cr 3,200.00 cr 5,100.00 cr
Cash & Bank Balance 38,200.00 cr35,100.00 cr32,000.00 cr28,500.00 cr25,200.00 cr22,000.00 cr19,800.00 cr
Net Worth 1,26,731.94 cr1,37,500.00 cr1,40,200.00 cr1,28,000.00 cr1,15,000.00 cr1,02,000.00 cr95,000.00 cr
EBITDA 27,865.49 cr29,800.00 cr30,200.00 cr27,000.00 cr24,500.00 cr22,000.00 cr20,100.00 cr

Financial Ratios

Revenue P/L EBITDA

Values in Crores (Cr) - illustrative trend

FY 2021 - FY 2025
Key Insights (FY 2025)
Revenue2,20,083.04 cr ▼ 6.5%
Profit/Loss13,969.70 cr ▲ 190.6%
EBITDA27,865.49 cr
Net Profit Margin10.54%
Debt/Equity0.47
Current Ratio0.88
Return on Equity12.3%
Ratio FY 2025FY 2024FY 2023FY 2022FY 2021
Net Profit Margin10.543.202.101.800.50
Debt to EBITDA2.141.901.701.501.20
Interest Coverage Ratio0.470.500.450.400.35
Debt to Equity0.880.900.850.800.75
Return on Equity12.103.002.001.500.20
Current Ratio1.201.151.101.050.99
Quick Ratio0.950.920.880.850.80
EBITDA Margin12.0010.008.007.005.00
Return on Capital Employed8.002.001.000.200.00
Earning Per Share4.000.000.000.000.00

LLP Contribution

Contribution Pattern (FY 2025)
  • Promoters 33.19%
  • DII 23.22%
  • FII 18.28%
  • Public 22.89%
  • Others 2.42%
Contribution Pattern over the Year
Category 20252024202320222021
Promoters33.19%33.50%33.80%34.00%34.41%
DII23.22%22.90%22.50%22.10%21.80%
FII18.28%18.00%17.60%17.20%16.90%
Public22.89%23.10%23.50%24.00%24.20%
Others2.42%2.50%2.60%2.70%2.69%

EPFO Establishments (1)

MRNOI0019835000 Closed/All Member Excluded
StatusCode No Allotted Was Before Online Registration Started.
ActivityPaper
StateUttar Pradesh
Coverage07-JUN-1995

Current Partners (2)

A
Designated Partner | Since 2021-05-14
K
Designated Partner | Since 2021-05-14

Flagged By Authority

Regulatory and exchange flags (preview)

Frequently Asked Questions about Blue Paradigm Pharmaceuticals Llp
What is LLPIN/FCRN number of Blue Paradigm Pharmaceuticals Llp?
The Limited Liability Partnership Identification Number (LLPIN) for Blue Paradigm Pharmaceuticals Llp is AAX-0199.
When was Blue Paradigm Pharmaceuticals Llp incorporated?
Blue Paradigm Pharmaceuticals Llp was incorporated 5 years 19 days ago on 14 May 2021.
Who are the current designated partners and partners of Blue Paradigm Pharmaceuticals Llp?
Currently 2 partners are associated with Blue Paradigm Pharmaceuticals Llp: Avinash Shiv Singh Negi, Kedar Avinash Vidhwans.
  • Avinash Shiv Singh Negi
  • Kedar Avinash Vidhwans
What is the registered address of Blue Paradigm Pharmaceuticals Llp?
As per Ministry of Corporate Affairs (MCA), the registered address of Blue Paradigm Pharmaceuticals Llp is Office No 1302, Building No A1, Sector 1, Mbp, Mahape, Navi Mumbai, Maharashtra, 400710, India.
What is the ROC code of Blue Paradigm Pharmaceuticals Llp?
Blue Paradigm Pharmaceuticals Llp ROC code is Roc Mumbai.
What is the company classification of Blue Paradigm Pharmaceuticals Llp?
Blue Paradigm Pharmaceuticals Llp is classified as Limited Liability Partnership.
What is the current status of Blue Paradigm Pharmaceuticals Llp?
Blue Paradigm Pharmaceuticals Llp is currently Active and registered in Navi Mumbai, Maharashtra, India.
What industry or business activity is Blue Paradigm Pharmaceuticals Llp associated with?
Blue Paradigm Pharmaceuticals Llp lists activity aligned with: Pharma - Pharmaceutical Retailers & Distributors. See the Overview and Competition sections for fuller industry context.
What is the turnover or revenue of Blue Paradigm Pharmaceuticals Llp?
Turnover and revenue appear in filed financial statements when available. Open the Financial tab on this profile for revenue, profit or loss, balance sheet metrics, and related MCA filings - not headline estimates.
How can I get the financial details of Blue Paradigm Pharmaceuticals Llp?
You can view revenue, profit or loss, balance sheet metrics, and related filings on the Financial tab of this company profile.